Nucleic acid constructs for gene therapy whose activity is affected by inhibitors of cyclin-dependent kinases
A Standard patent application filed on 18 December 1998 credited to Eilers, Martin ; Sedlacek, Hans-Harald ; Buergin, Andrea

Details

Application number :

97204  

Application type :

Standard  

Application status :

CEASED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Nucleic acid constructs for gene therapy whose activity is affected by inhibitors of cyclin-dependent kinases  

Inventor :

Eilers, Martin ; Sedlacek, Hans-Harald ; Buergin, Andrea  

Agent name :

WATERMARK PATENT AND TRADE MARKS ATTORNEYS  

Address for service :

Level 2 302 Burwood Road HAWTHORN VIC 3122  

Filing date :

18 December 1998  

Associated companies :

 

Applicant name :

Aventis Pharma Deutschland GmbH  

Applicant address :

Gebaude K801, 65926, Frankfurt am main Germany  

Old name :

Hoechst Marion Roussel Deutschland GmbH  

Original Source :

Go  

Same Inventor

• Binding partners for inhibitors of cyclin-dependent kinases and...